Skip to main content
. 2020 Aug 17;9(8):e19053. doi: 10.2196/19053

Table 1.

Overview of study hypotheses and research questions.

Measures Outcomes Timeframe Hypothesis or question
Primary outcome



Bodyweight scale Change in body mass (in kilograms) 12 weeks Those in the Keyto intervention arm will achieve greater weight loss at 12 weeks than those in the Weight Watchers arm.
Secondary outcome



Bodyweight scale




Change in body mass
(in kilograms)
24 and 48 weeks Those in the Keyto intervention arm will achieve greater weight loss at 24 and 48 weeks than those in the Weight Watchers arm.


Change in body mass
(in kilograms)
Daily weight measured during the first 12 weeks What are the patterns of body mass change during the first 12 weeks between the 2 study groups?

Automated self-administered 24-hour dietary recall




Carbohydrate intake in 24-hour period
(in grams)
12, 24, and 48 weeks Those in the Keyto intervention arm will report lower carbohydrate intake at 12, 24, and 48 weeks.


Total fat, saturated fat, polyunsaturated fat, monounsaturated fat intake in 24-hour period (in grams) 12, 24, and 48 weeks Does the Keyto intervention or WW app intervention influence fat intake from baseline to 12, 24, and 48 weeks?


Total energy intake in 24-hour period
(in kilocalories)
12, 24, and 48 weeks

We will examine changes from baseline to 12, 24, and 48 weeks in total energy intake in the Keyto and Weight Watchers groups.

Venous blood sample HbA1ca, fasting glucose, fasting insulin, fasting high-sensitivity C-reactive protein, fasting HOMA-IRb, fasting total cholesterol, fasting HDLc cholesterol, fasting lipoprotein fractions, fasting lipoprotein (a), fasting triglycerides, fasting non-HDL cholesterol 12 and 48 weeks We will examine changes from baseline to 12 and 48 weeks in metabolic and cardiovascular risk blood biomarkers in the Keyto and Weight Watchers groups.
Exploratory outcome



Venous blood sample Fasting albumin, fasting globulin, fasting total bilirubin, fasting alkaline phosphatase, fasting aspartate aminotransferase, fasting alanine aminotransferase 12 and 48 weeks We will explore changes from baseline to 12 and 48 weeks in blood biochemistry in the Keyto and Weight Watchers group.
Manipulation checks



Questionnaires




Food attitude survey 12, 24, and 48 weeks We will examine all baseline questionnaires as potential covariates. We will also examine differences in questionnaire measures between the 2 groups at 12, 24, and 48 weeks.


Cravings, mood, and energy Weekly


Self-reported dietary adherence Weekly


Pittsburgh Sleep Quality Index 12, 24, and 48 weeks

aHbA1c: hemoglobin A1c.

bHOMA-IR: homeostasis model assessment of insulin resistance.

cHDL: high-density lipoprotein.